Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
SAR444200 + Atezolizumab for Cancer
Recruiting1 awardPhase 1 & 2
Toronto, Ontario
This trial is testing a new drug called SAR444200, either alone or with other cancer treatments. It targets adults with advanced cancer who have already received other treatments. The study will check if the drug is safe, how it behaves in the body, and if it helps treat cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service